Navigation Links
CyberKnife Treatment for Medically Inoperable Lung Cancer
Date:9/9/2009

CyberKnife®, a highly developed technology designed to treat tumors, gives new options for those with medically inoperable lung cancer.

Phoenix, Arizona (Vocus) September 9, 2009 -- Today, DoctorFinders.com (http://doctorfinders.com/) highlights information about CyberKnife®, a new technology offering treatment options for medically inoperable lung cancer.

Medically inoperable cancer can be both frightening and frustrating to treat, primarily because the option of having it removed surgically is unavailable. Pre-existing conditions such as lung disease, chronic obstructive pulmonary disease, or heart disease, impede treatment because of the high risk of complications or even death during surgery.

Left with no other alternative, patients have traditionally turned to treatments that are painful, invasive and destructive, such as chemotherapy, radiofrequency ablation and cryotherapy. These procedures attack the cancer broadly, damaging both cancerous and healthy tissue.

Fortunately, there’s a better option today – one that allows patients a much-improved chance to avoid this unpleasant outcome: The CyberKnife Robotic Radiosurgery System®. This new technology is designed to treat tumors, including inoperable lung cancer, with pinpoint accuracy. This technology exclusively targets the tumor with a precise dose of radiation so the surrounding healthy tissue is spared.

Dr. Jamie Cesaretti, an oncologist who uses the CyberKnife system, commented, "CyberKnife
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Twitter Users Can Follow in Real Time as Local Woman Receives Cyberknife Treatment for Lung Cancer
2. Accuray Announces CyberKnife Access Remote Service Product
3. First Customer Installs CyberKnife System in Existing Radiation Therapy Vault
4. First CyberKnife System in Rhode Island Installed
5. 10th CyberKnife System Installed at an HCA Hospital
6. Turkish Ministry of Health Purchases Two CyberKnife(R) Systems
7. CyberKnife Center of Miami Executive Director James G. Schwade M.D. Garners Ultimate Miami CEO Award
8. Dr. James Hevezi Appointed as Chief Physicist for CyberKnife Center of Miami
9. Next Generation CyberKnife Increases Patient Throughput at Philadelphia CyberKnife
10. Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications
11. CyberKnife Radiosurgery Used to Treat More Than 3,000 Prostate Cancer Patients Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CyberKnife Treatment for Medically Inoperable Lung Cancer
CyberKnife Treatment for Medically Inoperable Lung Cancer
(Date:12/15/2009)... cardiovascular event, suicide goes up within a week ... 15 (HealthDay News) -- Emotional stress can put ... for cardiovascular events and suicide, a new study ... Swedish men diagnosed with prostate cancer between 1961 ... experienced a cardiovascular event within a year of ...
(Date:12/15/2009)... Reportlinker.com announces that a ... in its catalogue: ,, In-Vitro ... U.S. and its International Trade [Q4 ... ,, The newly published In-Vitro ... the latest market research on the ...
(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...
(Date:12/15/2009)... STAMFORD, Conn., Dec. 15 Aon ... of Aon Corporation (NYSE: AON ... the firm as senior vice president with ... of the national Pharmacy Practice. ,, ... her new role, Zeitel will work under ...
(Date:12/15/2009)... Ill. and CHENNAI, India, Dec. 15 /PRNewswire-FirstCall/ ... ), the world leader in generic injectable ... (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian ... beta-lactam antibiotics manufacturers globally, today announced an ... injectable finished-dosage form pharmaceuticals business for approximately ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Health News:Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 2Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 3Health News:Aon Consulting Adds Senior Vice President to National Pharmacy Practice 4Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 2Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 3Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 4Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 5Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 6
... increases 88% and net premiums written increase 22% over the ... comparable year-earlier quarterly results, FARMINGTON, ... or "Our") (NYSE:,DR) today announced its financial results for the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060829/NETU014LOGO ), -- Gross ...
... Rights to Bystolic(TM) (Nebivolol) for $370 Million in Cash ... To Consider a Sale of Dey Specialty Business, PITTSBURGH, Feb. ... results for the three and nine months ended,December 31, 2007, provided ... announced a number of strategic and operational,initiatives., Financial Highlights, ...
... Offers Unique Formulation of Important Cancer Medication -, ... Inc.,(NYSE: HSP ), the world leader in ... hydrochloride injection in the United,States. The medication is ... U.S. sales of more than $545 million. Irinotecan ...
... board of trustees approved a proposal today to create ... pharmacy program will serve a total of 300 students ... of 2010., The proposal, which was presented to ... two years of research and study conducted by,members of ...
... Dr. Shawn Hook of Arbor Ridge,Clinic in Madison, Wisconsin ... Great Vectra 3D(TM)" $125,000 Giveaway. Dr. Hook is the,first ... in,medical equipment for his veterinary clinic. There will be ... March, and a final grand prize,winner who will win ...
... WASHINGTON, Feb. 27 Children with special,needs will ... environment levels in,District households. Health Services for Children ... Safe D.C., has begun offering free,in-home lead testing ... needs. The collaboration will initially focus on children ...
Other Medicine News:Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 6Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 7Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 2Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 3Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 4Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 5Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 6Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 7Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 8Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 9Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 10Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 11Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 12Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 13Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 14Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 15Health News:Hospira Launches Generic Irinotecan Injection 2Health News:Hospira Launches Generic Irinotecan Injection 3Health News:Hospira Launches Generic Irinotecan Injection 4Health News:PC Trustees Vote to Start New Pharmacy School in S.C. 2Health News:PC Trustees Vote to Start New Pharmacy School in S.C. 3Health News:Summit VetPharm Announces First Winner in its 'Great Vectra 3D(TM)' $125,000 Giveaway 2Health News:Lead Safe D.C. and HSCSN Bring Lead Poisoning Prevention to The District's Children With Special Needs 2
(Date:12/15/2009)... -- Sinovac Biotech Ltd. ( SVA),a leading ... today,that Weidong Yin, Chairman, President & CEO, ... be one of 18 nominees for China,s ... CCTV,s Economic Man-of-the-Year is the country,s most ... as the "Oscar Award of the,Chinese Economy." ...
(Date:12/15/2009)... Accumetrics, Inc., developer and marketer of the VerifyNow® ... for measuring an individual,s response to multiple antiplatelet ... the number of international and U.S. distribution agreements, ... significant capital financing that will take the company ... continued its commitment to creating a powerful, worldwide ...
(Date:12/15/2009)... LAWRENCE, Mass., Dec. 15 OBP Medical ... comfort and overall patient satisfaction in hospitals. ,, ... measuring the positive effects of OBP Medical,s Under ... hospital stay. A hospital wide survey is comparing ... of their stay while wearing Under Johnnies(TM) against ...
Breaking Medicine Technology:Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 2Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award 3Accumetrics Closes 2009 with Positive Outlook 2Accumetrics Closes 2009 with Positive Outlook 3Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc. 2Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 1Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 2Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 3Accurays Euan Thomson Named Ernst 26 Young Entrepreneur Of The Year 28R 29 2009 Award Recipient in Northern California 49189 1Accurays Euan Thomson Named Ernst 26 Young Entrepreneur Of The Year 28R 29 2009 Award Recipient in Northern California 49189 2Accurays Euan Thomson Named Ernst 26 Young Entrepreneur Of The Year 28R 29 2009 Award Recipient in Northern California 49189 3Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 49187 1Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 49187 2Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital 49187 3
... SOPHIA ANTIPOLIS, France, May 11, 2007 /PRNewswire-FirstCall/ --,NicOx ... the phase 2a,study for NCX 1000, which is ... A preliminary analysis of 11 patients,from this ... of NCX 1000 but did not demonstrate the ...
... Italy--(BUSINESS WIRE)--May 14, 2007 - Acceleron Pharma,Inc., ... of musculoskeletal, metabolic and cancer-related,diseases, today announced ... demonstrated the ability of the compound to ... and in murine models of,muscular dystrophy. ACE-031 ...
Other Medicine Technology:NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 2Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in,Preclinical Studies 3
... allows you to tailor to your specialty. ... Synchronous Processing Technology. The technology delivers a ... all operational modes. Advanced Digital Signal architecture ... voltage over 450,000 times per second and ...
... based adhesive supplied as a phase ... a liquid substrate and crosslinker useful ... When combined the materials ... prepared wound and tenaciously adhere to ...
The DuraSeal System includes an innovative polyethylene glycol hydrogel sealant and applicator packaged in a single-use kit which can be stored at room temperature for convenience and quick preparati...
... DERMABOND* Topical Skin Adhesive gives you new ... is intended for topical application only to ... wounds from surgical incisions, including punctures from ... trauma-induced lacerations. DERMABOND adhesive may be used ...
Medicine Products: